 synthetic grafts

B

Systematic review240 of
22 RCTs with various
comparisons. Secondary
indirect evidence on
beneÔ¨Åts of antiplatelet
agents in reducing
cardiovascular morbidity
and mortality

Anticoagulants reduced the
risk of limb loss at the
longest follow-up (OR,
0.36; 95% CI, 0.19-0.69)
and